Literature DB >> 9185743

Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy.

A S Basile1, E A Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9185743     DOI： 10.1002/hep.510250636

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  22 in total

Review 1.  Psychiatric aspects of portal-systemic encephalopathy.

Authors:  J Wiltfang; W Nolte; K Weissenborn; J Kornhuber; E Rüther
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Hepatic encephalopathy as a complication of liver disease.

Authors:  S vom Dahl; G Kircheis; D Häussinger
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

3.  Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis.

Authors:  A Rovira; E Grivé; S Pedraza; A Rovira; J Alonso
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

Review 4.  Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?

Authors:  E A Jones; A S Basile
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 5.  The extrahepatic consequences of cirrhosis.

Authors:  Jin Kee Ho; Eric Yoshida
Journal:  MedGenMed       Date:  2006-03-02

6.  Effects of L-carnitine in patients with hepatic encephalopathy.

Authors:  Mariano Malaguarnera; Giovanni Pistone; Rampello Elvira; Carmelo Leotta; Linda Scarpello; Rampello Liborio
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 7.  Astroglial dysfunction in hepatic encephalopathy.

Authors:  M D Norenberg
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

8.  Amino acid challenge in patients with cirrhosis and control subjects: ammonia, plasma amino acid and EEG changes.

Authors:  Hanan Al Mardini; Andrew Douglass; Christopher Record
Journal:  Metab Brain Dis       Date:  2006-05-04       Impact factor: 3.584

Review 9.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

10.  Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.

Authors:  H P Meyer; D A Legemate; W van den Brom; J Rothuizen
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.